Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
June 12, 2024 07:00 ET
|
Evergold Corp.
Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
June 10, 2024 14:33 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Presents Advancement of LRP-661, Their Lead Drug Candidate, at the New Antiepileptic Drug Conference in Madrid, Spain
ProSearch Expands Client-Focused Leadership Team Amid Continued Growth
June 05, 2024 10:00 ET
|
ProSearch
LOS ANGELES, June 05, 2024 (GLOBE NEWSWIRE) -- ProSearch, a leading provider of legal data intelligence and comprehensive discovery and compliance solutions to corporate legal departments and law...
Evergold – CSAMT Survey Over DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
May 13, 2024 07:00 ET
|
Evergold Corp.
CSAMT Survey Over Evergold's DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
QuisLex Incorporates ContractPodAi’s Leah Generative AI Platform into Its Workflows
April 30, 2024 11:00 ET
|
QuisLex
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- QuisLex, a leading alternative legal services provider long recognized as a pioneer in the industry, announced today its expanded partnership with...
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
ProSearch Legal Discovery Experts to Share Insights, Contribute to Key Industry Initiatives at Upcoming Events
April 02, 2024 15:12 ET
|
ProSearch
LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- ProSearch, a leading provider of comprehensive discovery and compliance solutions to corporate legal departments and law firms, announces the...
Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024
March 07, 2024 04:00 ET
|
Oxford BioTherapeutics
OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discoveryOGAP-Verify is now more sensitive than...
Stelmine planifie une première campagne d’exploration sur ses propriétés du nord du district de Caniapiscau
March 04, 2024 09:55 ET
|
Stelmine Canada ltée
QUÉBEC, 04 mars 2024 (GLOBE NEWSWIRE) -- Stelmine Canada (“Stelmine” ou “la Société”) (TSXV: STH ). Stelmine planifie actuellement les campagnes de travaux de la saison estivale 2024.Cette...
Stelmine is planning a maiden exploration campaign on its northern Caniapiscau properties
March 04, 2024 09:55 ET
|
Stelmine Canada Ltd.
QUÉBEC CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Stelmine Canada (“Stelmine” or “the Company”) (TSXV: STH). Stelmine is currently planning its summer 2024 work program. This year, a first...